FDA Releases LDT Regulatory Framework, Notification Draft Guidances
This article was originally published in The Gray Sheet
Executive Summary
Two promised draft guidances on FDA’s framework for regulating laboratory developed tests and notification and medical device reporting requirements for LDTs have been posted. The agency wants swift notification from labs for most available LDTs once a framework is finalized.